MEDIROM Healthcare Technologies Inc. (MRM)
NASDAQ: MRM · Real-Time Price · USD
0.8700
-0.0442 (-4.84%)
At close: May 12, 2025, 4:00 PM
0.8820
+0.0120 (1.38%)
After-hours: May 12, 2025, 4:31 PM EDT
MRM Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 8,146 | 6,628 | 6,560 | 5,366 | 3,316 | Upgrade
|
| Other Revenue | 153.63 | 200.4 | 393.77 | 43.97 | 25.67 | Upgrade
|
| Revenue | 8,299 | 6,828 | 6,954 | 5,410 | 3,342 | Upgrade
|
| Revenue Growth (YoY) | 21.55% | -1.81% | 28.54% | 61.89% | -14.50% | Upgrade
|
| Cost of Revenue | 6,053 | 5,259 | 5,052 | 3,994 | 2,913 | Upgrade
|
| Gross Profit | 2,246 | 1,569 | 1,902 | 1,415 | 428.95 | Upgrade
|
| Selling, General & Admin | 2,242 | 1,960 | 1,805 | 1,811 | 1,069 | Upgrade
|
| Operating Expenses | 2,242 | 1,960 | 1,805 | 1,811 | 1,069 | Upgrade
|
| Operating Income | 4.77 | -391.58 | 96.97 | -395.38 | -639.59 | Upgrade
|
| Interest Expense | -49.75 | -36.87 | -9.8 | -11.95 | -13.23 | Upgrade
|
| Interest & Investment Income | 0.01 | 1.11 | 6.07 | 0.84 | 1.33 | Upgrade
|
| Currency Exchange Gain (Loss) | 18.12 | 26.83 | 14.83 | 14.99 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 56.8 | 7.45 | 71.7 | 52.22 | 131.3 | Upgrade
|
| EBT Excluding Unusual Items | 29.95 | -393.06 | 179.77 | -339.27 | -520.19 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -12 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 40.63 | 413.68 | - | - | - | Upgrade
|
| Asset Writedown | -22.87 | - | - | -63.21 | -106.5 | Upgrade
|
| Pretax Income | 47.71 | 20.62 | 179.77 | -414.48 | -626.69 | Upgrade
|
| Income Tax Expense | -90.48 | -94.43 | 30.81 | 576.25 | -87.52 | Upgrade
|
| Earnings From Continuing Operations | 138.19 | 115.05 | 148.97 | -990.73 | -539.17 | Upgrade
|
| Net Income to Company | 138.19 | 115.05 | 148.97 | -990.73 | -539.17 | Upgrade
|
| Minority Interest in Earnings | 10.57 | 0.36 | - | - | - | Upgrade
|
| Net Income | 148.76 | 115.4 | 148.97 | -990.73 | -539.17 | Upgrade
|
| Net Income to Common | 148.76 | 115.4 | 148.97 | -990.73 | -539.17 | Upgrade
|
| Net Income Growth | 28.91% | -22.53% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 5 | 5 | 5 | 4 | Upgrade
|
| Shares Change (YoY) | 13.26% | -5.56% | 12.16% | 21.19% | -5.80% | Upgrade
|
| EPS (Basic) | 29.13 | 23.64 | 30.54 | -203.13 | -133.97 | Upgrade
|
| EPS (Diluted) | 28.52 | 22.34 | 27.23 | -203.13 | -133.97 | Upgrade
|
| EPS Growth | 27.65% | -17.96% | - | - | - | Upgrade
|
| Free Cash Flow | -1,403 | -767.58 | -806.44 | -652.88 | -439.98 | Upgrade
|
| Free Cash Flow Per Share | -239.78 | -148.56 | -147.41 | -133.86 | -109.32 | Upgrade
|
| Gross Margin | 27.07% | 22.98% | 27.36% | 26.16% | 12.84% | Upgrade
|
| Operating Margin | 0.06% | -5.73% | 1.39% | -7.31% | -19.14% | Upgrade
|
| Profit Margin | 1.79% | 1.69% | 2.14% | -18.31% | -16.13% | Upgrade
|
| Free Cash Flow Margin | -16.91% | -11.24% | -11.60% | -12.07% | -13.17% | Upgrade
|
| EBITDA | 294.81 | -138.98 | 281.02 | -269.13 | -577.3 | Upgrade
|
| EBITDA Margin | 3.55% | -2.04% | 4.04% | -4.98% | -17.28% | Upgrade
|
| D&A For EBITDA | 290.04 | 252.6 | 184.06 | 126.24 | 62.29 | Upgrade
|
| EBIT | 4.77 | -391.58 | 96.97 | -395.38 | -639.59 | Upgrade
|
| EBIT Margin | 0.06% | -5.73% | 1.39% | -7.31% | -19.14% | Upgrade
|
| Effective Tax Rate | - | - | 17.14% | - | - | Upgrade
|
| Revenue as Reported | 8,299 | 6,828 | 6,954 | 5,410 | 3,342 | Upgrade
|
| Advertising Expenses | 155.36 | 162.03 | 135.13 | 130.96 | 92.46 | Upgrade
|
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.